Ji Li

Franck Le Deu, a Senior Partner at McKinsey, and Ji Li, a former BD executive at major biopharmas, delve into the booming collaboration between Western and Chinese biotechs. They examine the surge in cross-border deals driven by China's maturing biotech ecosystem. The conversation reveals the Hong Kong Stock Exchange's role as a hotspot for biotech IPOs, shifting dynamics in deal-making, and the emergence of innovative companies in China. Insights on upcoming conferences and networking opportunities also highlight the future of global biopharma partnerships.